Boule Diagnostics Balance Sheet Health
Financial Health criteria checks 5/6
Boule Diagnostics has a total shareholder equity of SEK496.2M and total debt of SEK165.0M, which brings its debt-to-equity ratio to 33.3%. Its total assets and total liabilities are SEK802.9M and SEK306.7M respectively. Boule Diagnostics's EBIT is SEK41.1M making its interest coverage ratio 4.1. It has cash and short-term investments of SEK34.7M.
Key information
33.3%
Debt to equity ratio
SEK 165.00m
Debt
| Interest coverage ratio | 4.1x |
| Cash | SEK 34.70m |
| Equity | SEK 496.20m |
| Total liabilities | SEK 306.70m |
| Total assets | SEK 802.90m |
Recent financial health updates
We Think Boule Diagnostics (STO:BOUL) Can Stay On Top Of Its Debt
Mar 06
These 4 Measures Indicate That Boule Diagnostics (STO:BOUL) Is Using Debt Extensively
Jan 30Recent updates
Boule Diagnostics AB (publ) Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
Jul 25Capital Allocation Trends At Boule Diagnostics (STO:BOUL) Aren't Ideal
Jul 24Sentiment Still Eluding Boule Diagnostics AB (publ) (STO:BOUL)
Jun 06Results: Boule Diagnostics AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates
May 10Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate
Mar 20Here's What Analysts Are Forecasting For Boule Diagnostics AB (publ) (STO:BOUL) After Its Yearly Results
Feb 09Boule Diagnostics AB (publ) (STO:BOUL) Screens Well But There Might Be A Catch
Dec 30Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital
Jul 25Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 49% Below Their Intrinsic Value Estimate
May 26Boule Diagnostics' (STO:BOUL) Solid Profits Have Weak Fundamentals
Jul 26Returns On Capital Signal Tricky Times Ahead For Boule Diagnostics (STO:BOUL)
Jul 19We Think Boule Diagnostics (STO:BOUL) Can Stay On Top Of Its Debt
Mar 06Investors Could Be Concerned With Boule Diagnostics' (STO:BOUL) Returns On Capital
Feb 03The Returns At Boule Diagnostics (STO:BOUL) Aren't Growing
Apr 29Should You Investigate Boule Diagnostics AB (publ) (STO:BOUL) At kr67.70?
Apr 09Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 27% Below Their Intrinsic Value Estimate
Mar 25Consider This Before Buying Boule Diagnostics AB (publ) (STO:BOUL) For The 1.0% Dividend
Mar 07Is Boule Diagnostics' (STO:BOUL) 210% Share Price Increase Well Justified?
Feb 17
These 4 Measures Indicate That Boule Diagnostics (STO:BOUL) Is Using Debt Extensively
Jan 30Is Boule Diagnostics AB (publ)'s (STO:BOUL) Shareholder Ownership Skewed Towards Insiders?
Jan 14How Many Boule Diagnostics AB (publ) (STO:BOUL) Shares Did Insiders Buy, In The Last Year?
Dec 28Boule Diagnostics AB (publ) (STO:BOUL) Shares Could Be 47% Below Their Intrinsic Value Estimate
Dec 10What Do The Returns On Capital At Boule Diagnostics (STO:BOUL) Tell Us?
Nov 22Financial Position Analysis
Short Term Liabilities: BOUL's short term assets (SEK282.7M) exceed its short term liabilities (SEK229.4M).
Long Term Liabilities: BOUL's short term assets (SEK282.7M) exceed its long term liabilities (SEK77.3M).
Debt to Equity History and Analysis
Debt Level: BOUL's net debt to equity ratio (26.3%) is considered satisfactory.
Reducing Debt: BOUL's debt to equity ratio has increased from 31% to 33.3% over the past 5 years.
Debt Coverage: BOUL's debt is well covered by operating cash flow (50.5%).
Interest Coverage: BOUL's interest payments on its debt are well covered by EBIT (4.1x coverage).